Rare diseases
Investigational molecules
Locations
Back to France649 clinical trials in Pierre Benite, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
FranceStudy comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer
FranceStudy on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer
FranceStudy on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
FranceStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
FranceStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
FranceStudy on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma
FranceStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
FranceStudy Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on vaccine development against major viral infections. Studies include evaluations of new treatments for influenza, cytomegalovirus, and yellow fever.
Research aims to enhance prevention and protection against these significant viral threats.
Groundbreaking research in inflammatory bowel diseases, exploring innovative therapeutic approaches including fecal microbiota transplantation for both Crohn's disease and ulcerative colitis.
Studies focus on developing alternative treatment strategies for patients with limited therapeutic options.
Comprehensive research into blood cancers and solid tumors, including multiple myeloma, leukemia, and advanced prostate cancer. Trials evaluate novel therapeutic combinations and targeted treatments.
Focus on developing more effective and personalized treatment approaches.
Studies addressing heart failure prevention, chronic kidney disease, and metabolic disorders. Research includes evaluation of novel drug combinations and therapeutic strategies.
Emphasis on preventing disease progression and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
